Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta blockers in hypertension.

U Thadani

    The American Journal of Cardiology
    |November 10, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Beta-blockers effectively manage mild-to-moderate hypertension, with various types showing equal efficacy at appropriate doses. These drugs can be a first-line treatment, safely combined with other antihypertensives for better blood pressure control.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure.

    Heart disease (Hagerstown, Md.)·2001
    Same author

    Treatment of stable angina.

    Current opinion in cardiology·1999
    Same author

    Supersensitivity to serotonin- and histamine-induced arterial contraction following ovariectomy.

    European journal of pharmacology·1998
    Same author

    Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase.

    Circulation·1998
    Same author

    Choosing the most appropriate treatment for stable angina. Safety considerations.

    Drug safety·1998
    Same author

    FDA Panel report: January 1998.

    Circulation·1998
    Same journal

    Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

    The American journal of cardiology·2026
    Same journal

    ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

    The American journal of cardiology·2026
    Same journal

    Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

    The American journal of cardiology·2026
    Same journal

    Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

    The American journal of cardiology·2026
    Same journal

    Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

    The American journal of cardiology·2026
    Same journal

    Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

    The American journal of cardiology·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Beta-adrenoceptor antagonists are widely used for hypertension.
    • Different classes of beta blockers exist, including noncardioselective, cardioselective, and those with intrinsic sympathomimetic activity (ISA).

    Purpose of the Study:

    • To evaluate the efficacy and safety of beta-blockers in managing mild-to-moderate hypertension.
    • To compare different types of beta-blockers and their suitability as first-line therapy.

    Main Methods:

    • Review of clinical data on beta-blocker efficacy in hypertension.
    • Comparison of various beta-blocker subclasses (noncardioselective, cardioselective, ISA) regarding effectiveness and side effect profiles.
    • Analysis of pharmacokinetic properties and their influence on side effects.

    Related Experiment Videos

    Main Results:

    • All beta-blocker types are equally effective in mild-to-moderate hypertension when used in equipotent doses.
    • Beta-blockers can be combined with diuretics and vasodilators for enhanced blood pressure control.
    • Lipid solubility influences central nervous system side effects, while ISA may reduce cold extremities and cardioselectivity may reduce bronchospasm.

    Conclusions:

    • Beta-blockers are effective first-line agents for uncomplicated mild-to-moderate hypertension.
    • They offer a favorable side effect profile compared to alternative antihypertensives.
    • Effective management can be achieved with once or twice daily dosing.